Feedback of Treatment Intensification Data to Reduce Cardiovascular Disease Risk (FIT)

Completed · Not applicable

Conditions studied: Cardiovascular Disease (CVD) Risk Factors

In brief

The primary research question of this study is to determine whether measuring, reporting and feeding back information to primary care teams on the need for treatment intensification in patients at high risk for cardiovascular disease (CVD) can improve rates of treatment intensification and reduce levels of poorly controlled systolic blood pressure, LDL-c, and A1c.

Key facts

Study ID

NCT00517686

Run by

Kaiser Permanente

People needed

16584

Starts

2008-07-01

Expected to finish

2009-09-01

Last updated by the study team

2012-08-03

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Among the randomized medical facilities, we will study a population that is drawn from the PHASE registry and includes patients with at least one of the following:
• Diabetes, coronary artery disease; congestive heart failure; stroke/tia; peripheral artery disease; chronic kidney disease; hypertension; or hyperlipidemia
• PHASE patients must be in poor control for at least one CVD risk factor and meet study criteria for needing treatment intensification at some point during the 6-month period.

You may not qualify if…

• All patients eligible for the study will be included in the analyses
• There will be no exclusions based on clinical or other criteria.

Where it is running

• Kaiser Permanente - Division of Research — Oakland, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.